Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

A hair transplant using hair from the back of the head and pubic area was successful in creating a feminine hairline for a male-to-female transgender person.

Finasteride and dutasteride have limited use in feminising therapy and are not recommended for routine use.

Feminizing hormone therapy increases hair counts and improves hair-related quality of life, while masculinizing therapy may reduce large terminal hairs.

Feminizing hormone therapy increases kidney filtration rate.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Transgender acne treatment requires a tailored approach with ongoing topical treatments and ceramide-rich moisturizers.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Finasteride and dutasteride are not recommended for feminizing therapy due to limited effectiveness and potential risks.

A female dog with mixed male and female traits was treated successfully with surgery.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Both genetic and hormonal factors are crucial for bird sex differentiation, and disturbances can cause sex reversal.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.